mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.03 |